| Literature DB >> 32410698 |
Lena Theres1,2, Anne Hübscher3, Karl Stangl3,4, Henryk Dreger3,4, Fabian Knebel3,4,5, Anna Brand3,4, Bernd Hewing3,4,5,6,7.
Abstract
BACKGROUND: We aimed to evaluate associations of right atrial (RA) and right ventricular (RV) strain parameters assessed by 2D speckle tracking echocardiography (2D STE) with invasively measured hemodynamic parameters in patients with and without pulmonary hypertension (PH).Entities:
Keywords: 2D speckle tracking echocardiography; Hemodynamic; Post-capillary pulmonary hypertension; Pulmonary hypertension; Right atrial strain; Right ventricular strain
Mesh:
Year: 2020 PMID: 32410698 PMCID: PMC7227096 DOI: 10.1186/s12947-020-00197-z
Source DB: PubMed Journal: Cardiovasc Ultrasound ISSN: 1476-7120 Impact factor: 2.062
Fig. 1Representative example of speckle tracking echocardiography (2D STE-) derived longitudinal strain of the right atrium obtained in the apical 4-chamber view. Dotted white curve indicates mean of all segments. The maximum excursion of the average strain curve [1] symbolizes the maximum longitudinal strain and RA reservoir function (RAS). RA conduit function was calculated from the difference between RAS and the end of the conduit phase in early diastole [2] and RA contractile function was derived from the difference between the endpoint of conduit phase and the peak RA contraction [3]
Fig. 2Representative example of speckle tracking echocardiography (2D STE-) derived longitudinal strain of the right ventricle obtained in the apical 4-chamber view. Dotted white curve indicates mean of all segments, where RVS is derived from maximum excursion. The RV Free wall consists of three segments, which are colored red, dark blue and pink in the STE analysis
Baseline characteristics
| Characteristic | All ( | PH ( | Non-PH ( | |
|---|---|---|---|---|
| Number of patients, n (%) | 78 | 45 (57.7) | 33 (42.3) | |
| Age, years | 72.6 ± 12.8 | 75.1 ± 11.5 | 69.3 ± 13.9 | |
| Gender female/male, n (%) | 17 (22.0) / 61 (78.0) | 16 (35.6) / 29 (64.4) | 32 (97.0)/ 1 (3.0) | |
| BMI, kg/m2 | 26.0 (24.0–29.4) | 26.7 (24.0–29.5) | 24.9 (24.0–27.8) | 0.107 |
| Heart rate, /min | 71.0 ± 12.3 | 72.6 ± 13.4 | 68.8 ± 10.2 | 0.181 |
| SBP, mmHg | 137.0 (118.7–150.0) | 137.0 (116.0–149.0) | 137.0 (121.5–153.5) | 0.671 |
| DBP, mmHg | 68.4 ± 12.3 | 68.9 ± 13.3 | 67.8 ± 11.1 | 0.693 |
| AF, n (%) | 21 (26.9) | 16 (35.6) | 5 (15.2) | |
| Diabetes, n (%) | 23 (29.5) | 17 (37.8) | 6 (18.2) | 0.061 |
| Arterial hypertension, n (%) | 56 (71.8) | 35 (77.8) | 21 (63.6) | 0.170 |
| CAD, n (%) | 33 (42.3) | 24 (53.3) | 9 (27.3) | |
| Previous MI, n (%) | 13 (16.7) | 10 (22.2) | 3 (9.1) | 0.124 |
| Previous CABG, n (%) | 7 (9.0) | 6 (13.3) | 1 (3.0) | 0.116 |
| Previous TIA/stroke, n (%) | 5 (6.4) | 3 (6.7) | 2 (6.1) | 0.914 |
| PAD, n (%) | 8 (10.3) | 6 (13.3) | 2 (6.1) | 0.296 |
| Previous bAVR, n (%) | 4 (5.1) | 3 (6.7) | 1 (3.0) | 0.472 |
| PM, n (%) | 14 (17.9) | 10 (22.2) | 4 (12.1) | 0.251 |
| ICD, n (%) | 2 (2.6) | 2 (4.4) | 0 | 0.220 |
| COPD, n (%) | 16 (20.5) | 13 (28.9) | 3 (9.1) |
Data are expressed as mean ± SD, median with IQR or absolute numbers and respective percentages. AF, atrial fibrillation; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; CAD, coronary artery disease; MI, myocardial infarction; CABG, coronary artery bypass grafting; TIA, transient ischemic attack; PAD, peripheral artery disease; bAVR, bioprosthetic aortic valve replacement; PM, pace maker; ICD, implantable cardioverter defibrillator; COPD, chronic obstructive pulmonary disease.
Echocardiographic and cardiac catheterization data
| Parameter | All ( | PH ( | Non-PH ( | |
|---|---|---|---|---|
| RA area, cm2 | 16.9 (13.0–24.9) | 20.2 (15.8–27.0) | 14.2 (12.3–18.0) | |
| RVED area, cm2 | 21.9 (17.9–25.6) | 22.1 (18.7–27.3) | 20.4 (15.8–25.4) | 0.130 |
| RVES area, cm2 | 12.2 (9.9–15.6) | 13.1 (10.8–17.1) | 10.7 (9.3–13.4) | |
| FAC, % | 41.3 (32.7–49.1) | 41.0 (33.0–48.4) | 43.5 (32.3–53.3) | 0.749 |
| RV base diameter, mm | 38.2 (33.5–42.9) | 39.6 (34.6–43.9) | 36 (30.3–40.7) | 0.104 |
| RV mid diameter, mm | 26.6 (22.1–32.7) | 29.3 (22.4–34.6) | 24.8 (21.5–31.5) | 0.146 |
| RV apex-base diameter, mm | 77.4 (66.3–84.2) | 77.6 (66.3–84.9) | 75.8 (66.4–81.8) | 0.402 |
| RVOT mm | 32.3 ± 4.3 | 32.5 ± 4.1 | 31.8 ± 4.5 | 0.54 |
| TAPSE, mm | 19.8 ± 5.6 | 17.8 ± 5.4 | 22.3 ± 4.7 | |
| RV-S′, cm/s | 10.9 ± 3.1 | 10.0 ± 3.1 | 12.2 ± 2.6 | |
| RVOT VTI | 13.1. ± 4.0 | 12.0 ± 4.2 | 14.6 ± 3.2 | |
| RV-e‘cm/s | 10.7 ± 3.3 | 10.6 ± 3.8 | 10.7 ± 2.7 | |
| RV-a’cm/s | 12.7 ± 5.6 | 11.3 ± 6.4 | 14.2 ± 4.3 | |
| LV ejection fraction, % | 45.0 ± 13.4 | 39.0 ± 12.4 | 52.4 ± 11.0 | |
| | 25 (32.1) | 8 (17.8) | 17 (51.5) | |
| 17 (21.8) | 8 (17.8) | 9 (27.3) | ||
| 27 (34.6) | 21 (46.7) | 6 (18.2) | ||
| | 9 (11.5) | 8 (17.8) | 1 (3.0) | |
| LV-GPLS | −13.6 ± 5.5 | −11.2 ± 5.3 | −16.5 ± 4.3 | |
| Aortic valve regurgitation, n (%) | 0.122 | |||
| 42 (53.8) | 20 (44.4) | 22 (66.7) | ||
| 25 (32.1) | 16 (35.6) | 9 (27.3) | ||
| 9 (11.5) | 8 (17.8) | 1 (3) | ||
| severe | 2 (2.6) | 1 (2.2) | 1 (3) | |
| Aortic valve stenosis, n (%) | 0.544 | |||
| 54 (69.2) | 29 (64.4) | 25 (75.8) | ||
| 1 (1.3) | 1 (2.2) | 0 | ||
| 1 (1.3) | 1 (2.2) | 0 | ||
| 22 (28.2) | 14 (31.1) | 8 (24.2) | ||
| Mitral valve regurgitation, n (%) | ||||
| 16 (20.5) | 8 (17.8) | 8 (24.2) | ||
| 27 (34.6) | 9 (20.0) | 18 (54.5) | ||
| 30 (38.5) | 25 (55.6) | 5 (15.2) | ||
| 5 (6.4) | 3 (6.7) | 2 (6.1) | ||
| Mitral valve stenosis, n (%) | 0.675 | |||
| 75 (96.2) | 43 (95.6) | 32 (97.0) | ||
| 2 (2.6) | 1 (2.2) | 1 (3.0) | ||
| 1 (1.3) | 1 (2.2) | 0 | ||
| Tricuspid valve regurgitation, n (%) | ||||
| 18 (23.1) | 5 (11.1) | 13 (39.4) | ||
| 31 (39.7) | 16 (35.6) | 15 (45.5) | ||
| 21 (26.9) | 16 (35.6) | 5 (15.2) | ||
| 8 (10.3) | 8 (17.8) | 0 | ||
| Pulmonary valve regurgitation, n (%) | 0.060 | |||
| 50 (64.1) | 24 (53.3) | 26 (78.8) | ||
| 27 (34.6) | 20 (44.4) | 7 (21.2) | ||
| 1 (1.3) | 1 (2.2) | 0 | ||
| mPAP, mmHg | 28.0 (21.0–36.0) | 35.0 (30.0–42.5) | 20.0 (17.0–22.5) | |
| PCWP, mmHg | 20.0 ± 9.0 | 25.9 ± 6.8 | 11.8 ± 3.9 | |
| Cardiac index, ml/min/m2 | 2.2 ± 0.6 | 2.0 ± 0.6 | 2.4 ± 0.4 | |
| LVEDP, mmHg | 20.0 (14.5–27.5) | 24.5 (21.0–30.7) | 15.0 (13.0–17.5) | |
| SVR, dyn x sec x cm−5 | 1619.5 (1345–2029.0) | 1712.0 (1344–2178.0) | 1536.0 (1334–1794.0) | 0.189 |
| PVR, dyn x sec x cm−5 | 205.5 (138.2–251.0) | 212.0 (164.5–288.5) | 180.0 (111.0–238.5) | 0.056 |
Data are expressed as mean ± SD, median with IQR, or absolute numbers and respective percentages. PH, pulmonary hypertension; RA, right atrial; RV, right ventricular; RVED and RVES, RV end diastolic and end systolic; FAC, fractional area change; TAPSE, tricuspid annular plane systolic excursion; RV-S′, RV peak systolic velocity; LV-GLPS, left ventricular global longitudinal peak systolic strain; LVEDP, left ventricular enddiastolic pressure; mPAP, mean pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure; SVR, systemic vascular resistance; PVR, pulmonary vascular resistance
Right atrial (RA) and right ventricular (RV) strain parameters
| Parameter | All (n = 78) | PH (n = 45) | Non-PH (n = 33) | |
|---|---|---|---|---|
| RAS, % | 19.5 (10.4–26.9) | 14.8 (7.5–26.3) | 21.3 (15.3–29.9) | 0.060 |
| Conduit function, %* | 10.0 (5.8–14.7) | 7.5 (3.7–14.7) | 11.7 (7.6–15.6) | 0.063 |
| Contractile function, %* | 11.8 (8.4–15.8) | 11.1 (5.3–13.9) | 13.5 (9.2–16.5) | 0.870 |
| RVS, % | −12.3 ± 6.5 | −11.5 ± 6.3 | −13.6 ± 6.8 | 0.196 |
| Basal strain, % | −21.4 ± 9.3 | −20.4 ± 10.7 | − 23.0 ± 6.1 | 0.210 |
| Mid strain, % | −19 ± 7.3 | −17.4 ± 7.8 | − 21.6 ± 5.5 | |
| Apical strain, % | − 9.3 (− 16.9 - -5.9) | −8.8 (− 15.2 - -5.8) | −11.1 (− 18.7 - -6.6) | 0.350 |
| Free Wall, % | −17.2 ± 6.5 | −16.15 ± 7.1 | −19.0 ± 4.8 | 0.072 |
Data are expressed as mean ± SD or median with IQR. PH, pulmonary hypertension; RAS, mean right atrial reservoir strain; RVS, mean right ventricular strain; * = atrial fibrillation, RA conduit and contraction function was only calculated for 59 patients (PH n = 30, non-PH n = 29).
Correlation analysis of mean right atrial (RA) and right ventricular (RV) strain parameters with invasively obtained hemodynamic parameters
| PH (n = 45) | Non-PH (n = 33) | |||||||
|---|---|---|---|---|---|---|---|---|
| correlation coefficient | correlation coefficient | p value | correlation coefficient | p value | correlation coefficient | p value | ||
| RA area | 0.297 | 0.050 | 0.189 | 0.219 | 0.043 | 0.814 | 0.281 | 0.126 |
| RVED area | 0.106 | 0.598 | 0.142 | 0.489 | ||||
| RVES area | 0.271 | 0.078 | − 0.026 | 0.899 | 0.026 | 0.900 | ||
| FAC | 0.089 | 0.572 | 0.130 | 0.407 | 0.157 | 0.434 | 0.031 | 0.882 |
| RV base diameter | 0.051 | 0.792 | 0.213 | 0.277 | ||||
| RV mid diameter | 0.251 | 0.104 | 0.188 | 0.227 | −0.182 | 0.343 | 0.182 | 0.355 |
| RV apex-base diameter | 0.077 | 0.626 | 0.104 | 0.507 | − 0.073 | 0.705 | − 0.258 | 0.184 |
| TAPSE | 0.181 | 0.233 | 0.245 | 0.154 | 0.310 | 0.085 | ||
| RV-S′ | 0.166 | 0.294 | 0.453 | 0.10 | −0.069 | 0.717 | ||
| RVOT VTI | −0.222 | 0.16 | 0.377 | 0.044 | 0.059 | 0.77 | ||
| RV-e‘ | 0.200 | 0.20 | 0.132 | 0.40 | 0.269 | 0.14 | ||
| RV-a‘ | −0,275 | 0.13 | −0,104 | 0.58 | −0.111 | 0.56 | ||
| RAS | −0.017 | 0.923 | −0.177 | 0.334 | ||||
| Conduit function * | −0.342 | 0.065 | −0.171 | 0.366 | 0.259 | 0.175 | −0.019 | 0.924 |
| Contractile function * | −0.335 | 0.071 | −0.242 | 0.198 | 0.045 | 0.818 | −0.018 | 0.927 |
| RVS | −0.130 | 0.520 | −0.052 | 0.802 | ||||
| Basal strain | 0.131 | 0.404 | 0.062 | 0.763 | −0.307 | 0.135 | ||
| mid strain | 0.260 | 0.092 | −0.180 | 0.378 | −0.024 | 0.910 | ||
| Apical strain | −0.298 | 0.139 | 0.242 | 0.244 | ||||
| Free Wall | 0.258 | 0.094 | −0.277 | 0.265 | −0.061 | 0.773 | ||
PH, pulmonary hypertension; mPAP, mean pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure; RA, right atrial; RV, right ventricular; RVED and RVES, RV end diastolic and end systolic; FAC, fractional area change; TAPSE, tricuspid annular plane systolic excursion; RV-S′, RV peak systolic velocity; RAS, mean right atrial reservoir strain; * = atrial fibrillation, RA conduit and contraction function was only calculated for 59 patients (PH n = 30, non-PH n = 29); RVS = mean right ventricular strain